GBI is pleased to announce that we are swinging hammers on our state-of-the-art commercial facility
Goodwin Biotechnology Inc. (GBI) Announces First Commercial Contract Signing
Goodwin Biotechnology Inc. is now GBI, as Part of their Rebranding Initiative on their 30-Year Anniversary!
Goodwin Biotechnology, Inc. Is Now GBI!
Vaccines Present a Novel Strategy for Opioid Overdose Prevention
Theranostic Manufacturing Solutions
Leveraging Experience to Reduce Timelines for IND-Enabling Activities
Refining the Definition of a Biopharmaceutical Contract Development and Manufacturing Organization
Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer